A look into the latest developments in biopharmaceutical manufacturing and facilities.
Medical vials on production line at pharmaceutical factory, Pharmaceutical machine working pharmaceutical glass bottles production line, | Image credit: © Prasanth - stock.adobe.com
As the biopharmaceutical industry moves into the end of 2023, biopharmaceutical companies should take stock of the latest developments in biopharmaceutical manufacturing and facilities. Over the past few months, manufacturing has seen many facility expansions and openings throughout the globe, partnerships for outsourcing services, and various acquisitions and expansions of manufacturing companies.
Read this article in BioPharm International’s November 2023 Manufacturing and Facilities eBook.
Daria G. Husni is assistant editor with BioPharm International.
BioPharm International
eBook: Manufacturing and Facilities
November 2023
Pages: 26–28
When referring to this article, please cite it as Husni, D. Update on Facilities and Manufacturing Trends. BioPharm International’s Manufacturing and Facilities eBook. November 2023.
VERAXA and Voyager to Create Combined Business for Advancing Pipeline of Next-Gen Cancer Therapies
April 23rd 2025The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company that will focus on developing a pipeline of next-generation cancer therapies.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.